Loading...
OTC Markets
Totals
Securities
12,215
Dollar Vol
$1.9B
Share Vol
2.4B
Trades
233,588

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

SPHRY
Starpharma Holdings Ltd.

Sponsored ADR (1 ADS : 10 Ordinary)

0.713215

0.04122

6.13%

0.597 / 0.7734 (4700 x 4700)

Real-Time Best Bid & Ask: 01:34pm 07/18/2025
Delayed (15 Min) Trade Data: 09:41am 07/18/2025

0.5968

0.5968 - 0.713215

450

Market Cap calculated only for this class of securities.

28,104,705

Real-Time Level 2 Quote
Bid
Ask
MPID
MPID
Bid Price
Bid Price
Size
Size
Time
Time
Jane Street Capital, LLC
JANE
0.5972,50010:00
OTC NQB
OTCN
0.5971,20010:00
StoneX Financial Inc.
INTL
0.5971,00013:34
MCAP LLC
MCAP
0.59551,00012:22
Maxim Group LLC
MAXM
0.5671,00010:01
MPID
MPID
Ask Price
Ask Price
Size
Size
Time
Time
Jane Street Capital, LLC
JANE
0.77342,50013:34
OTC NQB
OTCN
0.77341,20013:34
StoneX Financial Inc.
INTL
0.77341,00013:34
MCAP LLC
MCAP
0.77531,00011:08
Maxim Group LLC
MAXM
0.81211,00013:34
More
Trade Data
Date
Date
Timestamp
Timestamp
Price
Price
$ Change
$ Change
Volume
Volume
07/18/202509:41:14
0.713215
0.12100
07/18/202509:30:02
0.5968
-0.08350
07/14/202514:04:25
0.672
0.05100
07/09/202510:39:54
0.62695
-0.01500
07/03/202512:52:41
0.639115
0.09100
More Irregular/odd lot trades, which are not considered for the Open, High, Low or Closing prices, are not shown in trade data table.
News
Appendix 3H - Notification of cessation of securitiesOTC Disclosure & News Service | 07/07/2025
Appendix 3H - Notification of cessation of securitiesOTC Disclosure & News Service | 04/03/2025
Appendix 2A - Application for quotation of securitiesOTC Disclosure & News Service | 04/03/2025
More
Company Description
Starpharma Holdings Limited (ASX: SPL, US OTC: SPHRY) is an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient. Our mission is to help patients with significant illnesses, such as cancer, achieve improved health outcomes and quality of life through the application of our unique dendrimer technology.
Videos

This company has not added any videos

OTCQX Best Market Logo
Joined OTCQX 03/2007
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
The Company’s board of directors includes at least two Independent Directors.
Securities
Other Starpharma Holdings Ltd. Securities
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.